Prognozy (mln) dla China National Medicines Corporation Ltd.
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
52,477.06 |
53,288.33 |
56,129.33 |
59,395.50 |
| Przychód Δ r/r |
0.00% |
1.55% |
5.33% |
5.82% |
| Przychód (min) |
51,972.17 |
53,278.30 |
55,428.39 |
58,680.75 |
| Przychód (max) |
53,069.14 |
53,298.37 |
56,501.08 |
60,110.25 |
| EBITDA (średnia) |
3,034.53 |
3,081.44 |
3,245.73 |
3,434.60 |
| EBIT (średnia) |
2,806.84 |
2,850.24 |
3,002.19 |
3,176.89 |
| EBIT % |
5.35% |
5.35% |
5.35% |
5.35% |
| Zysk netto (średni) |
1,999.69 |
2,125.20 |
2,238.50 |
2,402.20 |
| Zysk netto % |
3.81% |
3.99% |
3.99% |
4.04% |
| EPS (średnia) |
2.98 |
2.82 |
3.00 |
3.19 |
| Liczba analityków (Przychody) |
3 |
2 |
3 |
2 |
| Liczba analityków (EPS) |
1 |
1 |
2 |
1 |
| symbol |
600511.SS |
600511.SS |
600511.SS |
600511.SS |